20/20 BIOLABS, INC. Selling, General and Administrative Expense
20/20 BIOLABS, INC. (AIDX) reported Selling, General and Administrative Expense of $1.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- 20/20 BIOLABS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.29M, a 58.48% increase year-over-year.
- 20/20 BIOLABS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.35M, a 68.85% increase year-over-year.
- 20/20 BIOLABS, INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $814.81K.
- 20/20 BIOLABS, INC. selling, general and administrative expense for the quarter ending 2025-03-31 was $801.14K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-14 | $2.64M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.35M 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | $3.34M POS AM · filed 2026-04-06 | ||
| 2025-06-30 | $814.81K 10-Q · filed 2026-08-14 | $1.62M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $801.14K 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | $4.76M POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |